 | • レポートコード：MRC2Q12-17578 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ハイスループットシーケンシングNGSのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ハイスループットシーケンシングNGSのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ハイスループットシーケンシングNGSの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ハイスループットシーケンシングNGSのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのハイスループットシーケンシングNGSの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のハイスループットシーケンシングNGSの売上および2028年までの予測に焦点を当てています。 ハイスループットシーケンシングNGSのグローバル主要企業には、Eurofins Scientific、Natera、BGI、Illumina、Roche、LabCorp、Berry Genomics、Brooks Life Sciences、Macrogen、Personalis、Novogene、Genotypic Technology、Dna Linkなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ハイスループットシーケンシングNGS市場は、タイプとアプリケーションによって区分されます。世界のハイスループットシーケンシングNGS市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ターゲットシーケンシング、全エクソームシーケンシング、全ゲノムシーケンシング 【アプリケーション別セグメント】 病院＆診療所、バイオ医薬品会社、学術・研究機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ハイスループットシーケンシングNGS製品概要 - タイプ別市場（ターゲットシーケンシング、全エクソームシーケンシング、全ゲノムシーケンシング） - アプリケーション別市場（病院＆診療所、バイオ医薬品会社、学術・研究機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のハイスループットシーケンシングNGS販売量予測2017-2028 - 世界のハイスループットシーケンシングNGS売上予測2017-2028 - ハイスループットシーケンシングNGSの地域別販売量 - ハイスループットシーケンシングNGSの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ハイスループットシーケンシングNGS販売量 - 主要メーカー別ハイスループットシーケンシングNGS売上 - 主要メーカー別ハイスループットシーケンシングNGS価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ターゲットシーケンシング、全エクソームシーケンシング、全ゲノムシーケンシング） - ハイスループットシーケンシングNGSのタイプ別販売量 - ハイスループットシーケンシングNGSのタイプ別売上 - ハイスループットシーケンシングNGSのタイプ別価格 ・アプリケーション別市場規模（病院＆診療所、バイオ医薬品会社、学術・研究機関、その他） - ハイスループットシーケンシングNGSのアプリケーション別販売量 - ハイスループットシーケンシングNGSのアプリケーション別売上 - ハイスループットシーケンシングNGSのアプリケーション別価格 ・北米市場 - 北米のハイスループットシーケンシングNGS市場規模（タイプ別、アプリケーション別） - 主要国別のハイスループットシーケンシングNGS市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのハイスループットシーケンシングNGS市場規模（タイプ別、アプリケーション別） - 主要国別のハイスループットシーケンシングNGS市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のハイスループットシーケンシングNGS市場規模（タイプ別、アプリケーション別） - 主要国別のハイスループットシーケンシングNGS市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のハイスループットシーケンシングNGS市場規模（タイプ別、アプリケーション別） - 主要国別のハイスループットシーケンシングNGS市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのハイスループットシーケンシングNGS市場規模（タイプ別、アプリケーション別） - 主要国別のハイスループットシーケンシングNGS市場規模（トルコ、サウジアラビア） ・企業情報 Eurofins Scientific、Natera、BGI、Illumina、Roche、LabCorp、Berry Genomics、Brooks Life Sciences、Macrogen、Personalis、Novogene、Genotypic Technology、Dna Link ・産業チェーン及び販売チャネル分析 - ハイスループットシーケンシングNGSの産業チェーン分析 - ハイスループットシーケンシングNGSの原材料 - ハイスループットシーケンシングNGSの生産プロセス - ハイスループットシーケンシングNGSの販売及びマーケティング - ハイスループットシーケンシングNGSの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ハイスループットシーケンシングNGSの産業動向 - ハイスループットシーケンシングNGSのマーケットドライバー - ハイスループットシーケンシングNGSの課題 - ハイスループットシーケンシングNGSの阻害要因 ・主な調査結果 |
Next Generation Sequencing (NGS), also known as high-throughput sequencing or deep-sequencing (Deep-sequencing), can sequence and analyze hundreds of thousands to millions of DNA fragments at a time. In 2014, the journal Nature Methods selected NGS technology as the first of the top ten technologies that have had the greatest impact on biological research in the past decade.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for High-Throughput Sequencing NGS estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for High-Throughput Sequencing NGS is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for High-Throughput Sequencing NGS is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for High-Throughput Sequencing NGS is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of High-Throughput Sequencing NGS include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the High-Throughput Sequencing NGS companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional High-Throughput Sequencing NGS market. Further, it explains the major drivers and regional dynamics of the global High-Throughput Sequencing NGS market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
High-Throughput Sequencing NGS Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
High-Throughput Sequencing NGS Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the High-Throughput Sequencing NGS market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for High-Throughput Sequencing NGS market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of High-Throughput Sequencing NGS, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for High-Throughput Sequencing NGS, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the High-Throughput Sequencing NGS revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global High-Throughput Sequencing NGS market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for High-Throughput Sequencing NGS revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of High-Throughput Sequencing NGS in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High-Throughput Sequencing NGS companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, High-Throughput Sequencing NGS revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High-Throughput Sequencing NGS Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 Market by Application
1.3.1 Global High-Throughput Sequencing NGS Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global High-Throughput Sequencing NGS Market Perspective (2017-2028)
2.2 High-Throughput Sequencing NGS Growth Trends by Region
2.2.1 High-Throughput Sequencing NGS Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 High-Throughput Sequencing NGS Historic Market Size by Region (2017-2022)
2.2.3 High-Throughput Sequencing NGS Forecasted Market Size by Region (2023-2028)
2.3 High-Throughput Sequencing NGS Market Dynamics
2.3.1 High-Throughput Sequencing NGS Industry Trends
2.3.2 High-Throughput Sequencing NGS Market Drivers
2.3.3 High-Throughput Sequencing NGS Market Challenges
2.3.4 High-Throughput Sequencing NGS Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High-Throughput Sequencing NGS Players by Revenue
3.1.1 Global Top High-Throughput Sequencing NGS Players by Revenue (2017-2022)
3.1.2 Global High-Throughput Sequencing NGS Revenue Market Share by Players (2017-2022)
3.2 Global High-Throughput Sequencing NGS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by High-Throughput Sequencing NGS Revenue
3.4 Global High-Throughput Sequencing NGS Market Concentration Ratio
3.4.1 Global High-Throughput Sequencing NGS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High-Throughput Sequencing NGS Revenue in 2021
3.5 High-Throughput Sequencing NGS Key Players Head office and Area Served
3.6 Key Players High-Throughput Sequencing NGS Product Solution and Service
3.7 Date of Enter into High-Throughput Sequencing NGS Market
3.8 Mergers & Acquisitions, Expansion Plans
4 High-Throughput Sequencing NGS Breakdown Data by Type
4.1 Global High-Throughput Sequencing NGS Historic Market Size by Type (2017-2022)
4.2 Global High-Throughput Sequencing NGS Forecasted Market Size by Type (2023-2028)
5 High-Throughput Sequencing NGS Breakdown Data by Application
5.1 Global High-Throughput Sequencing NGS Historic Market Size by Application (2017-2022)
5.2 Global High-Throughput Sequencing NGS Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America High-Throughput Sequencing NGS Market Size (2017-2028)
6.2 North America High-Throughput Sequencing NGS Market Size by Type
6.2.1 North America High-Throughput Sequencing NGS Market Size by Type (2017-2022)
6.2.2 North America High-Throughput Sequencing NGS Market Size by Type (2023-2028)
6.2.3 North America High-Throughput Sequencing NGS Market Share by Type (2017-2028)
6.3 North America High-Throughput Sequencing NGS Market Size by Application
6.3.1 North America High-Throughput Sequencing NGS Market Size by Application (2017-2022)
6.3.2 North America High-Throughput Sequencing NGS Market Size by Application (2023-2028)
6.3.3 North America High-Throughput Sequencing NGS Market Share by Application (2017-2028)
6.4 North America High-Throughput Sequencing NGS Market Size by Country
6.4.1 North America High-Throughput Sequencing NGS Market Size by Country (2017-2022)
6.4.2 North America High-Throughput Sequencing NGS Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe High-Throughput Sequencing NGS Market Size (2017-2028)
7.2 Europe High-Throughput Sequencing NGS Market Size by Type
7.2.1 Europe High-Throughput Sequencing NGS Market Size by Type (2017-2022)
7.2.2 Europe High-Throughput Sequencing NGS Market Size by Type (2023-2028)
7.2.3 Europe High-Throughput Sequencing NGS Market Share by Type (2017-2028)
7.3 Europe High-Throughput Sequencing NGS Market Size by Application
7.3.1 Europe High-Throughput Sequencing NGS Market Size by Application (2017-2022)
7.3.2 Europe High-Throughput Sequencing NGS Market Size by Application (2023-2028)
7.3.3 Europe High-Throughput Sequencing NGS Market Share by Application (2017-2028)
7.4 Europe High-Throughput Sequencing NGS Market Size by Country
7.4.1 Europe High-Throughput Sequencing NGS Market Size by Country (2017-2022)
7.4.2 Europe High-Throughput Sequencing NGS Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High-Throughput Sequencing NGS Market Size (2017-2028)
8.2 Asia-Pacific High-Throughput Sequencing NGS Market Size by Type
8.2.1 Asia-Pacific High-Throughput Sequencing NGS Market Size by Type (2017-2022)
8.2.2 Asia-Pacific High-Throughput Sequencing NGS Market Size by Type (2023-2028)
8.2.3 Asia-Pacific High-Throughput Sequencing NGS Market Share by Type (2017-2028)
8.3 Asia-Pacific High-Throughput Sequencing NGS Market Size by Application
8.3.1 Asia-Pacific High-Throughput Sequencing NGS Market Size by Application (2017-2022)
8.3.2 Asia-Pacific High-Throughput Sequencing NGS Market Size by Application (2023-2028)
8.3.3 Asia-Pacific High-Throughput Sequencing NGS Market Share by Application (2017-2028)
8.4 Asia-Pacific High-Throughput Sequencing NGS Market Size by Region
8.4.1 Asia-Pacific High-Throughput Sequencing NGS Market Size by Region (2017-2022)
8.4.2 Asia-Pacific High-Throughput Sequencing NGS Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America High-Throughput Sequencing NGS Market Size (2017-2028)
9.2 Latin America High-Throughput Sequencing NGS Market Size by Type
9.2.1 Latin America High-Throughput Sequencing NGS Market Size by Type (2017-2022)
9.2.2 Latin America High-Throughput Sequencing NGS Market Size by Type (2023-2028)
9.2.3 Latin America High-Throughput Sequencing NGS Market Share by Type (2017-2028)
9.3 Latin America High-Throughput Sequencing NGS Market Size by Application
9.3.1 Latin America High-Throughput Sequencing NGS Market Size by Application (2017-2022)
9.3.2 Latin America High-Throughput Sequencing NGS Market Size by Application (2023-2028)
9.3.3 Latin America High-Throughput Sequencing NGS Market Share by Application (2017-2028)
9.4 Latin America High-Throughput Sequencing NGS Market Size by Country
9.4.1 Latin America High-Throughput Sequencing NGS Market Size by Country (2017-2022)
9.4.2 Latin America High-Throughput Sequencing NGS Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High-Throughput Sequencing NGS Market Size (2017-2028)
10.2 Middle East & Africa High-Throughput Sequencing NGS Market Size by Type
10.2.1 Middle East & Africa High-Throughput Sequencing NGS Market Size by Type (2017-2022)
10.2.2 Middle East & Africa High-Throughput Sequencing NGS Market Size by Type (2023-2028)
10.2.3 Middle East & Africa High-Throughput Sequencing NGS Market Share by Type (2017-2028)
10.3 Middle East & Africa High-Throughput Sequencing NGS Market Size by Application
10.3.1 Middle East & Africa High-Throughput Sequencing NGS Market Size by Application (2017-2022)
10.3.2 Middle East & Africa High-Throughput Sequencing NGS Market Size by Application (2023-2028)
10.3.3 Middle East & Africa High-Throughput Sequencing NGS Market Share by Application (2017-2028)
10.4 Middle East & Africa High-Throughput Sequencing NGS Market Size by Country
10.4.1 Middle East & Africa High-Throughput Sequencing NGS Market Size by Country (2017-2022)
10.4.2 Middle East & Africa High-Throughput Sequencing NGS Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific High-Throughput Sequencing NGS Introduction
11.1.4 Eurofins Scientific Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.1.5 Eurofins Scientific Recent Developments
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera High-Throughput Sequencing NGS Introduction
11.2.4 Natera Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.2.5 Natera Recent Developments
11.3 BGI
11.3.1 BGI Company Details
11.3.2 BGI Business Overview
11.3.3 BGI High-Throughput Sequencing NGS Introduction
11.3.4 BGI Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.3.5 BGI Recent Developments
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina High-Throughput Sequencing NGS Introduction
11.4.4 Illumina Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.4.5 Illumina Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche High-Throughput Sequencing NGS Introduction
11.5.4 Roche Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.5.5 Roche Recent Developments
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp High-Throughput Sequencing NGS Introduction
11.6.4 LabCorp Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.6.5 LabCorp Recent Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics High-Throughput Sequencing NGS Introduction
11.7.4 Berry Genomics Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.7.5 Berry Genomics Recent Developments
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Details
11.8.2 Brooks Life Sciences Business Overview
11.8.3 Brooks Life Sciences High-Throughput Sequencing NGS Introduction
11.8.4 Brooks Life Sciences Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.8.5 Brooks Life Sciences Recent Developments
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen High-Throughput Sequencing NGS Introduction
11.9.4 Macrogen Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.9.5 Macrogen Recent Developments
11.10 Personalis
11.10.1 Personalis Company Details
11.10.2 Personalis Business Overview
11.10.3 Personalis High-Throughput Sequencing NGS Introduction
11.10.4 Personalis Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.10.5 Personalis Recent Developments
11.11 Novogene
11.11.1 Novogene Company Details
11.11.2 Novogene Business Overview
11.11.3 Novogene High-Throughput Sequencing NGS Introduction
11.11.4 Novogene Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.11.5 Novogene Recent Developments
11.12 Genotypic Technology
11.12.1 Genotypic Technology Company Details
11.12.2 Genotypic Technology Business Overview
11.12.3 Genotypic Technology High-Throughput Sequencing NGS Introduction
11.12.4 Genotypic Technology Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.12.5 Genotypic Technology Recent Developments
11.13 Dna Link
11.13.1 Dna Link Company Details
11.13.2 Dna Link Business Overview
11.13.3 Dna Link High-Throughput Sequencing NGS Introduction
11.13.4 Dna Link Revenue in High-Throughput Sequencing NGS Business (2017-2022)
11.13.5 Dna Link Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer